Loading company…
PROMETHERA develops stem cell treatments intended to support liver health and address liver disease.
Founded in 2009 by Etienne Sokal, PROMETHERA Biosciences is based in Mont-Saint-Guibert, Belgium. It develops cell therapies for patients with liver disease, including HepaStem™, which is described as having anti-fibrotic, anti-inflammatory, and immunomodulatory benefits. In December 2019, the company raised EUR 7.5 million in Series D funding co-led by Sony Ventures, Fenox Venture Capital, Medipal Holdings Co., Ltd, and Six Snow.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in